| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |